5-73017229-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138782.3(FCHO2):āc.717A>Gā(p.Ile239Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000104 in 1,540,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_138782.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCHO2 | NM_138782.3 | c.717A>G | p.Ile239Met | missense_variant | 8/26 | ENST00000430046.7 | NP_620137.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCHO2 | ENST00000430046.7 | c.717A>G | p.Ile239Met | missense_variant | 8/26 | 1 | NM_138782.3 | ENSP00000393776.2 | ||
FCHO2 | ENST00000287761.7 | c.717A>G | p.Ile239Met | missense_variant | 8/11 | 1 | ENSP00000287761.6 | |||
FCHO2 | ENST00000512348.5 | c.618A>G | p.Ile206Met | missense_variant | 7/25 | 2 | ENSP00000427296.1 | |||
FCHO2 | ENST00000507345.6 | c.642A>G | p.Ile214Met | missense_variant | 7/7 | 5 | ENSP00000426842.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000249 AC: 4AN: 160686Hom.: 0 AF XY: 0.0000236 AC XY: 2AN XY: 84852
GnomAD4 exome AF: 0.0000108 AC: 15AN: 1388348Hom.: 0 Cov.: 27 AF XY: 0.0000146 AC XY: 10AN XY: 685370
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152358Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74520
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2023 | The c.717A>G (p.I239M) alteration is located in exon 8 (coding exon 8) of the FCHO2 gene. This alteration results from a A to G substitution at nucleotide position 717, causing the isoleucine (I) at amino acid position 239 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at